ORTHOPEDIATRICS CORP (KIDS) Net Income (Loss) Attributable to Parent USD 2016 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Orthopediatrics Corp quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2016 to 2024.
  • Orthopediatrics Corp Net Income (Loss) Attributable to Parent for the quarter ending March 31, 2024 was -$7.81 M, a 14.7% decline year-over-year.
  • Orthopediatrics Corp Net Income (Loss) Attributable to Parent for the twelve months ending March 31, 2024 was -$22 M, a 719% decline year-over-year.
  • Orthopediatrics Corp annual Net Income (Loss) Attributable to Parent for 2023 was -$21 M, a 1767% decline from 2022.
  • Orthopediatrics Corp annual Net Income (Loss) Attributable to Parent for 2022 was $1.26 M.
  • Orthopediatrics Corp annual Net Income (Loss) Attributable to Parent for 2021 was -$16.3 M, a 50.6% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$22 M -$7.81 M -$999 K -14.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 -$21 M -$6.69 M +$1.16 M +14.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-08
Q3 2023 -$22.1 M -$4.59 M -$23.1 M -125% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $999 K -$2.89 M -$2.55 M -767% Apr 1, 2023 Jun 30, 2023 10-Q 2023-11-07
Q1 2023 $3.55 M -$6.81 M +$2.29 M +25.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $1.26 M -$7.85 M -$7.92 M -11000% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-08
Q3 2022 $9.18 M $18.5 M +$20.7 M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 -$11.6 M -$333 K +$3.42 M +91.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-07
Q1 2022 -$15 M -$9.1 M +$1.28 M +12.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-07
Q4 2021 -$16.3 M $72 K +$14.1 M Oct 1, 2021 Dec 31, 2021 10-K 2024-03-08
Q3 2021 -$30.3 M -$2.2 M +$2.34 M +51.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-01
Q2 2021 -$32.7 M -$3.76 M +$5.69 M +60.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-01
Q1 2021 -$38.4 M -$10.4 M -$5.43 M -110% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-01
Q4 2020 -$32.9 M -$14 M -$8.58 M -158% Oct 1, 2020 Dec 31, 2020 10-K 2021-03-11
Q3 2020 -$24.4 M -$4.54 M -$1.88 M -70.4% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$22.5 M -$9.45 M -$6.83 M -261% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-04
Q1 2020 -$15.7 M -$4.95 M -$1.93 M -63.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-04
Q4 2019 -$13.7 M -$5.43 M -$2.96 M -120% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-11
Q3 2019 -$10.8 M -$2.66 M -$799 K -42.8% Jul 1, 2019 Sep 30, 2019 10-K 2021-03-11
Q2 2019 -$9.97 M -$2.62 M +$74 K +2.75% Apr 1, 2019 Jun 30, 2019 10-K 2021-03-11
Q1 2019 -$10 M -$3.02 M +$1.98 M +39.6% Jan 1, 2019 Mar 31, 2019 10-K 2021-03-11
Q4 2018 -$12 M -$2.47 M +$2.38 M +49.1% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-05
Q3 2018 -$14.4 M -$1.87 M -$329 K -21.4% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-05
Q2 2018 -$14.1 M -$2.69 M -$1.43 M -113% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-05
Q1 2018 -$12.6 M -$5 M -$3.72 M -289% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-05
Q4 2017 -$8.93 M -$4.85 M -$1.21 M -33.4% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-07
Q3 2017 -$7.72 M -$1.54 M -$690 K -81.6% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-07
Q2 2017 -$7.03 M -$1.27 M -$978 K -340% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-07
Q1 2017 -$6.05 M -$1.29 M +$520 K +28.8% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-07
Q4 2016 -$6.57 M -$3.63 M Oct 1, 2016 Dec 31, 2016 10-K 2018-03-15
Q3 2016 -$846 K Jul 1, 2016 Sep 30, 2016 10-K 2018-03-15
Q2 2016 -$288 K Apr 1, 2016 Jun 30, 2016 10-K 2018-03-15
Q1 2016 -$1.81 M Jan 1, 2016 Mar 31, 2016 10-K 2018-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.